139 related articles for article (PubMed ID: 7299692)
1. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
O'Reilly RA; Goulart DA
J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
O'Reilly RA; Trager WF; Motley CH; Howald W
J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.
O'Reilly RA
Circulation; 1982 Jan; 65(1):202-7. PubMed ID: 7053283
[TBL] [Abstract][Full Text] [Related]
4. The stereoselective interaction of warfarin and metronidazole in man.
O'Reilly RA
N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
O'Reilly RA
Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
[TBL] [Abstract][Full Text] [Related]
6. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
[TBL] [Abstract][Full Text] [Related]
7. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
O'Reilly RA
Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
[TBL] [Abstract][Full Text] [Related]
8. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
[TBL] [Abstract][Full Text] [Related]
9. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
O'Reilly RA; Trager WF; Rettie AE; Goulart DA
Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
[TBL] [Abstract][Full Text] [Related]
10. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
Veronich K; White G; Kapoor A
J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
[TBL] [Abstract][Full Text] [Related]
11. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
Wosilait WD; Ryan MP; Byington KH
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
[TBL] [Abstract][Full Text] [Related]
12. Warfarin-phenylbutazone interaction in man: a long term multiple dose study.
Schary WL; Lewis RJ; Rowland M
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):663-72. PubMed ID: 1153844
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
He M; Kunze KL; Trager WF
Drug Metab Dispos; 1995 Jun; 23(6):659-63. PubMed ID: 7587949
[TBL] [Abstract][Full Text] [Related]
14. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
[TBL] [Abstract][Full Text] [Related]
15. Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?
O'Reilly RA
Clin Pharmacol Ther; 1982 Sep; 32(3):356-61. PubMed ID: 7105625
[TBL] [Abstract][Full Text] [Related]
16. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
17. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
Chan E; McLachlan AJ; Rowland M
Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
[TBL] [Abstract][Full Text] [Related]
18. Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin.
O'Reilly RA
Clin Pharmacol Ther; 1981 Mar; 29(3):332-6. PubMed ID: 7471603
[TBL] [Abstract][Full Text] [Related]
19. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
He J; Shibukawa A; Tokunaga S; Nakagawa T
J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.
Banfield C; O'Reilly R; Chan E; Rowland M
Br J Clin Pharmacol; 1983 Dec; 16(6):669-75. PubMed ID: 6661352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
